Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 10/2005

01-12-2005

Anthropometrics, Physical Activity, Related Medical Conditions, and the Risk of Non-Hodgkin Lymphoma

Authors: James R. Cerhan, Leslie Bernstein, Richard K Severson, Scott Davis, Joanne S. Colt, Aaron Blair, Patricia Hartge

Published in: Cancer Causes & Control | Issue 10/2005

Login to get access
Metadata
Title
Anthropometrics, Physical Activity, Related Medical Conditions, and the Risk of Non-Hodgkin Lymphoma
Authors
James R. Cerhan
Leslie Bernstein
Richard K Severson
Scott Davis
Joanne S. Colt
Aaron Blair
Patricia Hartge
Publication date
01-12-2005
Publisher
Kluwer Academic Publishers
Published in
Cancer Causes & Control / Issue 10/2005
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-005-0358-7

Other articles of this Issue 10/2005

Cancer Causes & Control 10/2005 Go to the issue

OriginalPaper

Colorectal Cancer Incidence Among Female Textile Workers in Shanghai, China: A Case-cohort Analysis of Occupational Exposures

OriginalPaper

Reducing Cigarette Smoking Among Working Adolescents: Results from the SMART Study

OriginalPaper

MnSOD Val-9Ala Genotype, Pro- and Anti-oxidant Environmental Modifiers, and Breast Cancer Among Women on Long Island, New York

OriginalPaper

Occupational Exposures and Mycosis Fungoides. A European Multicentre Case–control Study (Europe)

OriginalPaper

The Estrogen Receptor α Gene and Breast Cancer Risk (The Netherlands)

OriginalPaper

Effects of a School-based Obesity-prevention Intervention on Menarche (United States)
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits